CD8A and cancer: The same principle has been applied to cancer therapy for example, when it was discovered that cytotoxic T cells were being suppressed by PD1 ligands secreted by tumour cells, it was thought that anti‐PD1 inhibitor monoclonal antibody would reactivate CD8+ T cells and would effect a cure.